GlassScriptPhysician profile
Krishanthan Vigneswaran
NPI 1437418746
$8,622.63
in general payments reported to CMS, 2019-2025
24 companies · $7,122 in 2025
The $7,122 reported for 2025 was more than what 83% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.89 · 2020: $101 · 2021: $37.92 · 2022: $526 · 2023: $464 · 2024: $341 · 2025: $7,122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $3,500 · Travel and Lodging: $2,582 · Food and Beverage: $1,845.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $3,500.00 |
| Travel and Lodging | $2,581.75 |
| Food and Beverage | $1,845.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Brainlab, INC. | $4,648.18 | 2020-2025 | Brainlab, INC. |
| Alphatec Spine, INC | $2,048.09 | 2025 | Other - Miscellaneous |
| Stryker Corporation | $705.42 | 2019-2025 | Ozark Cervical Plate System, Yukon Oct Spinal System, Everest Spinal System |
| Providence Medical Technology, INC. | $172.54 | 2025 | |
| Globus Medical, INC. | $150.50 | 2022-2024 | Excelsius Deformity |
| Medtronic, INC. | $133.01 | 2021-2023 | Monosof |
| Nevro Corp. | $129.21 | 2022 | |
| Abbvie INC. | $117.75 | 2022-2024 | Botox |
| Intrinsic Therapeutics | $101.08 | 2025 | Barricaid Acd (Annular Closure Device) |
| Argenx US, INC. | $65.11 | 2023 | Vyvgart |
| Depuy Synthes Sales INC. | $48.46 | 2025 | Symphony, Spine & Trauma 3d Navigation |
| Silk Road Medical, INC. | $36.14 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Lilly USA, LLC | $35.91 | 2023 | Amyvid |
| Orthofix Medical, INC. | $24.35 | 2025 | Trinity Elite |
| Neurocrine Biosciences, INC. | $23.09 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $22.99 | 2025 | Rystiggo |
| Bioventus LLC | $22.12 | 2025 | Bonescalpel & Sonicone (O.R.) |
| Pacira Pharmaceuticals Incorporated | $21.78 | 2025 | Exparel |
| Servier Pharmaceuticals LLC | $21.75 | 2024 | |
| Allergan, INC. | $21.58 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.46 | 2022 | |
| Medinc of Texas | $20.09 | 2025 | |
| Eisai INC. | $18.36 | 2023 | |
| Boston Scientific Corporation | $14.66 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krishanthan Vigneswaran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.